ArticleJournal of hepatology2021
Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930-940].
Taesik Gwag et al.PubMed ↗Publisher ↗
No numbers read from the abstract.